首页> 外文期刊>Yonsei Medical Journal >Two Cases of Acute Leukopenia Induced by Colchicine with Concurrent Immunosuppressants Use in Beh?et's Disease
【24h】

Two Cases of Acute Leukopenia Induced by Colchicine with Concurrent Immunosuppressants Use in Beh?et's Disease

机译:秋水仙碱联合并用免疫抑制剂治疗白血球病急性白细胞减少症2例

获取原文
           

摘要

Colchicine-induced leukopenia usually occurrs in intentional or accidental overdoses or inappropriate use in combination with intravenous and oral colchine; however, there have been several reports of hematologic toxicity in short-term and small-dose colchicine medication courses. We present two cases of leukopenia induced by colchicine use concurrent with immunosuppressants in Beh?et's disease. We postulate that the mechanism of colchicine-induced leukopenia might be the destruction of circulating leukocytes and an inhibition of leukocyte production by the immediate and direct toxic effect of colchicine on idiosyncrasies unique to each patient. The concurrently administered immunosuppressant might decrease the threshold for hematologic toxicity of colchicine in the leukocytes and their precursor cells.
机译:秋水仙碱诱导的白细胞减少症通常发生于有意或无意的过量服用或与静脉和口服秋水仙碱联合使用不当;然而,短期和小剂量秋水仙碱药物疗程中有血液毒性的报道。我们提出了两例秋水仙碱引起的白细胞减少症,并伴有白塞特病的免疫抑制剂。我们推测秋水仙碱诱导的白细胞减少的机制可能是循环血白细胞的破坏和秋水仙碱对每位患者特有的特异的直接和直接毒性作用的抑制白细胞产生。同时使用免疫抑制剂可能会降低秋水仙碱对白细胞及其前体细胞血液学毒性的阈值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号